I'm currently taking Xtandi while waiting to start a CAR-T trial. Due to the way scheduling is working out, I'm starting and stopping Xtandi three times. It occurs to me that this might have a benefit similar to Bipolar Androgen Therapy, where it might delay resistance to Xtandi and kill more of the cancer.
Does anyone know if intermittent second generation androgen drug use has been tested?